The study covered in this summary was published in medRxiv.org as a preprint and has not yet been peer-reviewed. In the first study to describe the magnitude of coronary microvascular collateral ...
The emerging advantages of positron-emission tomography (PET) myocardial perfusion imaging (MPI) for coronary artery disease (CAD) diagnosis and assessment of cardiovascular event risk has prompted ...
GE HealthCare’s FDA-approved flurpiridaz F 18 PET radiotracer, Flyrcado, delivers higher diagnostic efficacy in patients with known or suspected coronary artery disease (CAD), compared to SPECT MPI, ...
The much-anticipated Flyrcado™ (flurpiridaz F 18) injection, a first-of-its-kind unit dose positron emission tomography myocardial perfusion imaging agent for the detection of coronary artery disease, ...
Milan, 18 September 2023 - A mathematical and computational model of the human heart entirely developed at Politecnico di Milano and designed for studying coronary artery disease. This is the focus of ...
Cleveland-based University Hospitals Harrington Heart & Vascular Institute has become the first site in Ohio to clinically administer Flyrcado for the detection of coronary artery disease and arterial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results